News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,601 Results
Type
Article (40904)
Company Profile (267)
Press Release (680420)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204666)
Career Advice (2023)
Deals (35534)
Drug Delivery (110)
Drug Development (81380)
Employer Resources (173)
FDA (16408)
Job Trends (14944)
News (346379)
Policy (32725)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2567)
Accelerated approval (31)
Adcomms (24)
Allergies (142)
Alliances (49575)
ALS (169)
Alzheimer's disease (1667)
Antibody-drug conjugate (ADC) (309)
Approvals (16675)
Artificial intelligence (512)
Autoimmune disease (152)
Automation (38)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (637)
Cancer (4791)
Cardiovascular disease (398)
Career advice (1708)
Career pathing (36)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (739)
Cervical cancer (36)
Clinical research (69552)
Collaboration (1694)
Company closure (4)
Compensation (1155)
Complete response letters (54)
COVID-19 (2710)
CRISPR (87)
C-suite (841)
Cystic fibrosis (143)
Data (6208)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (499)
Diagnostics (6685)
Digital health (48)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (250)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90129)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (117263)
Executive appointments (971)
FDA (19512)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1464)
Gene editing (193)
Generative AI (43)
Gene therapy (593)
GLP-1 (965)
Government (4659)
Grass and pollen (6)
Guidances (383)
Healthcare (18871)
HIV (58)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (249)
Immuno-oncology (57)
Indications (109)
Infectious disease (2976)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (115)
Intellectual property (248)
Interviews (315)
IPO (16642)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (546)
Leadership (31)
Legal (7949)
Liver cancer (91)
Longevity (14)
Lung cancer (645)
Lymphoma (375)
Machine learning (42)
Management (59)
Manufacturing (790)
MASH (162)
Medical device (13766)
Medtech (13819)
Mergers & acquisitions (19961)
Metabolic disorders (1263)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (314)
Neuropsychiatric disorders (88)
Neuroscience (2890)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4512)
Now hiring (67)
Obesity (593)
Opinion (257)
Ovarian cancer (166)
Pain (197)
Pancreatic cancer (225)
Parkinson's disease (279)
Partnered (33)
Patents (494)
Patient recruitment (487)
Peanut (56)
People (58859)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21682)
Phase 2 (30612)
Phase 3 (22803)
Pipeline (5246)
Policy (281)
Postmarket research (2564)
Preclinical (9196)
Press Release (64)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (831)
Real estate (5954)
Recruiting (70)
Regulatory (24465)
Reports (52)
Research institute (2386)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (147)
Series A (238)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3614)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1000)
Venture capital (88)
Weight loss (379)
Women's health (89)
Worklife (18)
Date
Today (154)
Last 7 days (572)
Last 30 days (2081)
Last 365 days (29929)
2026 (3319)
2025 (30173)
2024 (35217)
2023 (40075)
2022 (51174)
2021 (55714)
2020 (54083)
2019 (46539)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39215)
Australia (6409)
California (11253)
Canada (3277)
China (1096)
Colorado (477)
Connecticut (475)
Delaware (335)
Europe (84498)
Florida (1683)
Georgia (354)
Hawaii (3)
Idaho (61)
Illinois (856)
India (65)
Indiana (519)
Iowa (22)
Japan (428)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1376)
Massachusetts (8069)
Michigan (323)
Minnesota (625)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2996)
New Mexico (28)
New York (2966)
North Carolina (1447)
North Dakota (8)
Northern California (5495)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2274)
Puerto Rico (24)
Rhode Island (47)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4379)
Tennessee (174)
Texas (1737)
United States (39899)
Utah (334)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (917)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
721,601 Results for "agenus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
Agenus to Host First 2026 Stakeholder Webcast
January 21, 2026
·
5 min read
Press Releases
Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab
January 21, 2026
·
8 min read
Press Releases
Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors
February 10, 2026
·
4 min read
Press Releases
France Expands National AAC Access for Agenus’ Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
January 12, 2026
·
7 min read
Press Releases
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness
January 16, 2026
·
8 min read
Press Releases
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
December 24, 2025
·
8 min read
Press Releases
Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report
November 5, 2025
·
2 min read
Press Releases
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC
November 19, 2025
·
6 min read
Press Releases
Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances
November 11, 2025
·
7 min read
1 of 72,161
Next
